Latanoprost: all 99 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Optic Nerve Head Strain in Non-glaucoma SubjectsRecruitingNCT07425535Early Phase 1
• 0.005% Latanoprost Gel for Nonsegmental VitiligoNot yet recruitingNCT07016113Phase 2
• Evaluation of Latanoprost Combined With Fractional Erbium- YAG LaserRecruitingNCT06239324Phase 1/2
• Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet CellsRecruitingNCT04957329Phase 4
• Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma SuspectsRecruitingNCT04401982Phase 4
• Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT04445519Phase 3Results posted
• Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAGCompletedNCT02829996Phase 2Results posted
• Stop Retinal Ganglion Cell Dysfunction StudyTerminatedNCT02390284Phase 3Results posted
• Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT02059278Phase 3Results posted
• Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit DoseCompletedNCT02017327Phase 4Results posted
• Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric GlaucomaCompletedNCT01527682Phase 2Results posted
• Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT01494753Phase 2Results posted
• Effects of Anti-Glaucoma Medications on the Ocular SurfaceTerminatedNCT01315574Phase 4Results posted
• Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01253902Phase 4Results posted
• Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been TreatedCompletedNCT01243567Phase 4Results posted
• Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension GlaucomaCompletedNCT01175902Not applicableResults posted
• Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous PatientsCompletedNCT01156012Phase 3Results posted
• Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma PatientsTerminatedNCT01151904Phase 4Results posted
• A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329CompletedNCT00934089Phase 2Results posted
• An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension SubjectsCompletedNCT00811564Phase 4Results posted
• How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?CompletedNCT00798694Phase 4Results posted
• A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.CompletedNCT00716859Phase 3Results posted
• The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the EyeCompletedNCT00705757Phase 4Results posted
• A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.CompletedNCT00595101Phase 2Results posted
• Circadian Rhythms of Aqueous Humor Dynamics in HumansCompletedNCT00572936Phase 2Results posted
• Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.CompletedNCT00572455Phase 2Results posted
• Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00541242Phase 4Results posted
• A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).CompletedNCT00383019Phase 3Results posted
• Effect of Age on Latanoprost 0.005% in Patients With GlaucomaCompletedNCT00224289Phase 4Results posted
• Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia AreataCompletedNCT07757867Not applicable
• Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin TartrateCompletedNCT06730516Early Phase 1
• Effect of Latanoprost on Optic Nerve PerfusionCompletedNCT06629129Phase 1
• Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical FormulationStatus unknownNCT05790941Early Phase 1
• Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.Status unknownNCT05606796Phase 4
• Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.CompletedNCT05513924Phase 2/3
• Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory EvaluationActive, not recruitingNCT04811326Phase 4
• Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)CompletedNCT04737928Not applicable
• Aqueous Humor Dynamic Components That Determine Intraocular Pressure VarianceCompletedNCT04412096Phase 4
• CATS Tonometer IOP Reduction Latanoprost Verses TimololStatus unknownNCT04178863Phase 4
• Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle GlaucomaStatus unknownNCT04098861Phase 4
• Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle GlaucomaCompletedNCT03966560Phase 4
• Eyenovia MiDD Usability StudyCompletedNCT03480906Not applicable
• A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI StudyCompletedNCT02822742Phase 3
• A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of GlaucomaStatus unknownNCT02792803Phase 4
• Blood Flow of Ophthalmic Artery and GlaucomaStatus unknownNCT02656979Not applicable
• Pupillary Response After Glaucoma MedicationCompletedNCT02522039Not applicable
• Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia AreataCompletedNCT02350023Phase 4
• Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion PressuresCompletedNCT02154217Phase 3
• Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular HypertensionTerminatedNCT02047630Phase 4
• Latanoprost for the Treatment of Menière's DiseaseStatus unknownNCT01973114Phase 2
• 24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionCompletedNCT01655758Phase 4
• A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT01481077Phase 2
• A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT01481051Phase 2
• Switching From Preserved to Preserved-free Treatments for Glaucoma.Status unknownNCT01433900Phase 3
• Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost TherapyStatus unknownNCT01426464Phase 2
• A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular HypertensionCompletedNCT01379144Phase 2
• Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant GlaucomaStatus unknownNCT01361841Not applicable
• Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface DiseaseCompletedNCT01254370Phase 2
• A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT01229982Phase 2
• Topical Application of Latanoprost in Diabetic RetinopathyCompletedNCT01225653Phase 4
• Effect of Alphagan and Xalatan Eye Drops on Corneal TemperatureCompletedNCT01201551Not applicable
• Efficacy Comparison of Xalatan and Azopt on POAG and OHStatus unknownNCT01084902Not applicable
• Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01060579Phase 2
• A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGCompletedNCT01037036Phase 2
• Central Corneal Thickness and 24-hour Fluctuation of Intraocular PressureCompletedNCT00941525Phase 4
• Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)CompletedNCT00913029Phase 4
• Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular PressureCompletedNCT00906594Phase 4
• A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle GlaucomaWithdrawnNCT00855517Phase 2
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompletedNCT00847483Phase 4
• A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)CompletedNCT00821002Phase 2
• A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle GlaucomaCompletedNCT00820300Phase 2
• Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®CompletedNCT00799682Phase 4
• Effects of Cosopt on IOP and on Ocular Diastolic Perfusion PressureStatus unknownNCT00796198Phase 4
• A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT00751127Phase 3
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within ScandinaviaCompletedNCT00751062Phase 3
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United KingdomCompletedNCT00751049Phase 3
• Effects of Latanoprost on Choroidal Blood Flow Regulation in Human SubjectsCompletedNCT00712400Not applicable
• Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT00706927Not applicable
• Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00650702Phase 2
• A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle GlaucomaCompletedNCT00647101Phase 4
• A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.CompletedNCT00638742Phase 1
• Comparison of Latanoprost Vs. TimololTerminatedNCT00579969Phase 2
• Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy VolunteersCompletedNCT00468988Phase 4
• Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00465621Phase 2
• Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.Status unknownNCT00440336Not applicable
• Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%CompletedNCT00440141Phase 4
• Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma DropsCompletedNCT00402493Not applicable
• 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed CombinationsCompletedNCT00397241Phase 4
• Influence of Prostaglandins on Ocular Blood Flow in Glaucoma PatientsCompletedNCT00308945Phase 4
• Latanoprost Versus FotilCompletedNCT00304785Phase 4
• Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery DeviceWithdrawnNCT00283764Phase 3
• A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaCompletedNCT00277498Phase 3
• Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureCompletedNCT00230763Phase 3
• Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia AreataCompletedNCT00187577Not applicable
• A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaCompletedNCT00159653Phase 3
• Corneal Versus Conjunctival Delivery Using a Delivery DeviceWithdrawnNCT00143429Phase 2
• Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.CompletedNCT00140062Phase 4
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure GlaucomaCompletedNCT00051181Phase 3
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT00051142Phase 3

← Latanoprost overview